These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related]
31. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic options for elderly patients with advanced non-small cell lung cancer. Avery EJ; Kessinger A; Ganti AK Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139 [TBL] [Abstract][Full Text] [Related]
33. [Clinical advances in the chemotherapy of non-small cell lung cancer]. Liao ML; Cheng BJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):480-2. PubMed ID: 15312563 [No Abstract] [Full Text] [Related]
34. [Treatment of non-small cell lung cancer: advanced (metastatic) disease. Guidelines of clinical practice made by the European Lung Cancer Working Party]. European Lung Cancer Working Party Rev Med Brux; 2007; 28(6):495-511. PubMed ID: 18265809 [TBL] [Abstract][Full Text] [Related]
35. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of localised forms of non small cell bronchial cancers: perspectives in 20003]. Depierre A; Quoix E; Milleron B Rev Mal Respir; 2003 Apr; 20(2 Pt 1):173-6. PubMed ID: 12844012 [No Abstract] [Full Text] [Related]
37. Outcome of patients with a performance status of 2 in the Multicenter Italian Lung Cancer in the Elderly Study (MILES). Perrone F; Di Maio M; Gallo C; Gridelli C J Clin Oncol; 2004 Dec; 22(24):5018-20; author reply 5020-1. PubMed ID: 15611521 [No Abstract] [Full Text] [Related]
38. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial. Lorusso V; Gebbia V; Spada M; Guida M; Cassano G; Brunetti C; Germano D; Nettis G; Izzi G; Galetta D; Giampaglia M; Silvestris N; Colucci G Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254 [TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. Pohl G; Krajnik G; Malayeri R; Müller RM; Klepetko W; Eckersberger F; Schäfer-Prokop C; Pokrajac B; Schmeikal S; Maier A; Ambrosch G; Woltsche M; Minar W; Pirker R Lung Cancer; 2006 Oct; 54(1):63-7. PubMed ID: 16926060 [TBL] [Abstract][Full Text] [Related]